Bio Plus Co., Ltd (KOSDAQ:099430)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,090.00
-70.00 (-1.36%)
Feb 27, 2026, 3:30 PM KST
-27.60%
Market Cap 313.24B
Revenue (ttm) 96.80B
Net Income (ttm) 16.05B
Shares Out 61.54M
EPS (ttm) 237.82
PE Ratio 21.40
Forward PE n/a
Dividend 50.00 (0.98%)
Ex-Dividend Date Dec 29, 2025
Volume 360,549
Average Volume 512,803
Open 5,160.00
Previous Close 5,160.00
Day's Range 5,090.00 - 5,180.00
52-Week Range 4,815.00 - 8,420.00
Beta 0.54
RSI 39.88
Earnings Date Feb 12, 2026

About Bio Plus

Bio Plus Co., Ltd engages in the research and development, production, and sale of bio products in South Korea. It offers dermal fillers under the SkinPlus – Hyal, Bio+ Dew, HyalDew, DeneB Classic, Stilea, and 3-Senses brand names. The company also provides medical products, including InterBlock, an absorbable anti-adhesion barrier; Synofil, a synovial fluid replacement; and Blad-Care, a solution to temporarily improve cystitis symptoms. In addition, it offers mesotherapy products, such as skin rejuvenation products under the Kiara Reju name; S... [Read more]

Industry Medical - Specialties
Sector Healthcare
Founded 2003
Employees 147
Stock Exchange KOSDAQ
Ticker Symbol 099430
Full Company Profile

Financial Performance

In 2024, Bio Plus's revenue was 66.41 billion, an increase of 2.10% compared to the previous year's 65.04 billion. Earnings were 14.15 billion, a decrease of -44.68%.

Financial Statements

News

There is no news available yet.